Nadia Traficante

6PUBLICATIONS
176CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 06, 2026
Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

|Feb 15, 2023
Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.

Chen Wang, Matthew S Block, Julie M Cunningham

|Nov 11, 2022
Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan.

Hung-Hsueh Chou, Sian Fereday, Anna DeFazio

|Oct 07, 2022
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.

Gwo Yaw Ho, Elizabeth L Kyran, Justin Bedo

|Mar 09, 2022
TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.

Rachel Delahunty, Linh Nguyen, Stuart Craig

Pageof 1

Frequent Collaborators

6 joint publications

David Dl Bowtell

5 joint publications

Sian Fereday

4 joint publications

Dinuka Ariyaratne

4 joint publications

Dale W Garsed